医学
表观遗传学
生物信息学
病态的
血管舒缩
精密医学
小RNA
神经科学
干细胞
转化医学
后生
线粒体
计算生物学
器官系统
个性化医疗
转化研究
病理
细胞
自噬
电池类型
衰老
系统生物学
健康衰老
老化
机制(生物学)
氧化应激
生理学
心血管健康
表型
血管疾病
代谢综合征
临床实习
作者
Ruoqi Wang,Stephen Y. Chan,Toren Finkel
出处
期刊:Circulation
[Lippincott Williams & Wilkins]
日期:2026-05-04
卷期号:153 (18): 1421-1435
标识
DOI:10.1161/circulationaha.125.075567
摘要
Vascular aging is a central determinant of healthy life span, not only influencing the susceptibility to cardiovascular diseases but also shaping the risk of systemic decline across multiple organs. It is driven by a variety of age-related factors, including cellular senescence, chronic inflammation, loss of proteostasis, mitochondrial dysfunction, genomic instability, epigenetic remodeling, and stem cell exhaustion. These processes interact with the unique mechanical and metabolic environment of the vasculature to create a distinctive pathological trajectory, manifested in part as arterial stiffening, impaired barrier integrity, and dysregulated vasomotor control. Recent advances in single-cell omics and cross-organ molecular clocks have revealed the heterogeneity and organ specificity of aging, underscoring the need for integrative frameworks that connect vascular biology with overall health. Meanwhile, the development of diverse therapeutic strategies-ranging from senolytic and immune-mediated clearance to metabolic and mitochondrial interventions-highlights the translational potential of targeting the aging vasculature. Looking ahead, multimodal biomarkers and precision medicine may transform vascular aging from an inevitable process into a modifiable determinant of health span.
科研通智能强力驱动
Strongly Powered by AbleSci AI